Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose rifampicin prophylaxis for contacts of multibacillary leprosy patients
RBR-69qk5pPhase 4Recruiting
- Sponsor
- Oswaldo Cruz Institute
- Start
- Jul 2015
- Modality
- Small Molecules, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial in leprosy (HD) comparing Rifampicin + BCG vaccine with Placebo + BCG vaccine (2 arms). Primary endpoint: Incidence of leprosy. Started Jul 2015; status: recruiting.
02
Drugs
rifampicinbcg vaccine
03
Conditions
leprosy (HD)
Beyond the preview
Go deeper on RBR-69qk5p.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-69qk5p.